Stopping cancer in its tracks?

by Tracey Peake
Stopping cancer in its tracks?

We've come a long way in cancer treatments – we have powerful, effective drugs for many types of cancer and we're moving toward ever more specific, less invasive therapies. But the problem with cancer is that it's always in motion, metastasizing and spreading throughout the body to overwhelm it. What if you could stop cancer in its tracks?

Ken Adler, a at NC State, may be on to a way to do just that. Adler, who studies cell movement in like and asthma, developed a peptide, or small , that stopped inflammation by inhibiting the movement of .

As it turns out, that peptide, called the MANS peptide (for Myristoylated Alanine-Rich N-terminus sequence, if you were wondering), looks like it may also be effective in stopping the movement of other cells, like lung-cancer cells.

In collaboration with a team of scientists from UC Davis including researcher Reen Wu, Adler showed that the MANS peptide stopped lung-cancer cells from moving, or metastasizing, in mice. Their research results appear in the journal Oncogene.

So how, exactly, does a peptide stop a cell from moving?

Adler has spent a very long time looking at a particular protein known as MARCKS (or Myristoylated Alanine-rich C Kinase Substrate) and its involvement in cell movement. When MARCKS is activated, it binds to the cell's cytoskeleton (the scaffolding inside a cell), and specifically to a protein called actin, which contracts, as well as to the inside of the cell membrane. MARCKS links the actin and the membrane so that actin's movement translates into cell movement.

MANS works by binding to the membrane at the sites that MARCKS would normally use, crowding MARCKS out. The actin is still doing its job, but the link between the actin and the membrane is broken and the cell stays put.

Adler plans to continue studying the mechanisms that make MARCKS work, as well as the effects of the MANS peptide on metastasis. "Once we get to the basic mechanism of MARCKS, we'll have a lot of tools at our disposal to use in treating cancer, as well as other diseases," he says.

add to favorites email to friend print save as pdf

Related Stories

Water governs cell movement

May 14, 2013

Water gives life. Researchers at Linköping University in Sweden now show how the cells in our bodies are driven mainly by water power – a discovery that in the long run opens the way for a new strategy ...

Study identifies protein required for cell movement

Aug 12, 2013

Both basic scientists and clinicians have an interest in how the cells of our body move. Cells must be mobile in order for organisms to grow, to heal, to transmit information internally, to mount immune responses and to conduct ...

Recommended for you

How does prostate cancer form?

1 hour ago

Prostate cancer affects more than 23,000 men this year in the USA however the individual genes that initiate prostate cancer formation are poorly understood. Finding an enzyme that regulates this process ...

Low risk of malignancy for small complex adnexal masses

8 hours ago

(HealthDay)—For older women with small complex adnexal masses, the overall risk of malignancy is low, according to a study published in the December issue of the American Journal of Obstetrics & Gynecology.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Aug 27, 2013
A drug blocking a path of one of the hallmarks of cancer, tissue invasion and metastasis, would be a very good news. http://en.wikiped...f_cancer

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.